http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002147159-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate | 2001-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3395a6c378347f0ab2fe1f4a43e59cbc |
publicationDate | 2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2002147159-A1 |
titleOfInvention | Method and composition for controlled release acarbose formulations |
abstract | The present invention is directed towards a method and composition for controlled release acarbose formulations. The method and composition disclosed herein combine acarbose and a sustained release matrix. The administration of acarbose alone has been shown to be useful in the treatment of diabetes. Although the initial studies conducted herein were conducted with a delayed release formulation that allowed partial sustained release administered to stimulate sustained release, all indicators from the present invention suggest the formulation of acarbose in a sustained release formulation would have heretofore unexpected benefits. In a sustained release formulation, the ingredient(s) would be a shaped dosage unit having a sustained and regular release of acarbose throughout the small intestine where carbohydrates as a simple sugar are absorbed. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-252865-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-252865-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1734953-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006044657-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101606921-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122054-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1734953-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109464414-A |
priorityDate | 2001-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.